8-K: VSee Health Reports Q2 2024 Financial Results and Business Update Following De-SPAC Transaction

VSee Health announced its second quarter 2024 financial results, highlighting a 33% revenue increase year-over-year and key strategic partnerships.

Summary

• VSee Health reported a revenue of $1.7 million for the second quarter of 2024, a 33% increase compared to $1.3 million in the same period of 2023.
• The revenue growth was primarily driven by a 93% increase in professional and other fees and a 290% increase in technical and engineering fees.
• Operating expenses increased by 69% due to higher transaction costs related to the business combination and increased general and administrative expenses.
• The net loss for the second quarter of 2024 was $0.3 million, or $0.06 per share, compared to a net loss of $0.4 million, or $0.09 per share, in the second quarter of 2023.
• For the first half of 2024, revenue was $3.2 million, an 11% increase from $2.9 million in the first half of 2023.
• The net loss for the first half of 2024 was $0.3 million, or $0.07 per share, compared to a net loss of $0.9 million, or $0.19 per share, in the first half of 2023.
• Pro forma results, including iDoc, show a revenue of $2.7 million for Q2 2024 compared to $2.8 million in Q2 2023, and a net loss of $1.8 million compared to $1.0 million.
• Pro forma results for the first half of 2024 show a revenue of $5.8 million compared to $6.3 million in the first half of 2023, and a net loss of $2.0 million compared to $2.1 million.
• As of June 30, 2024, VSee Health had cash and cash equivalents of $1.1 million.

Sentiment

Score: 7

Explanation: The sentiment is positive due to strong revenue growth, strategic partnerships, and a decrease in net losses. However, the increase in operating expenses and pro forma revenue decline temper the overall optimism.

Positives

• VSee Health's revenue increased by 33% in the second quarter of 2024 compared to the same period in 2023.
• The company has successfully completed its de-SPAC transaction and is now publicly traded.
• VSee Health has secured several strategic partnerships, including with Ava Robotics, Seven Corners Correctional Health, SkywardRx, and Premier, Inc.
• The launch of Aimee provides low-cost access to healthcare, potentially expanding the company's customer base.
• The net loss decreased by 16% in the second quarter of 2024 compared to the same period in 2023.
• The net loss decreased by 62% in the first half of 2024 compared to the same period in 2023.
• Technical and engineering fees increased by 290% in the second quarter, indicating strong demand for their services.

Negatives

• Operating expenses increased by 69% in the second quarter of 2024 compared to the same period in 2023.
• The company experienced a net loss of $0.3 million in the second quarter of 2024.
• Pro forma revenue decreased slightly in both the second quarter and first half of 2024 compared to the same periods in 2023.
• Pro forma net loss increased in the second quarter of 2024 compared to the same period in 2023.
• Subscription revenue declined by 6% in the first half of 2024 due to churned enterprise customers.

Risks

• The company's operating expenses are increasing significantly, which could impact profitability.
• The company is still experiencing net losses, although they are decreasing.
• The pro forma results show a decrease in revenue and an increase in net loss, indicating potential challenges in integrating the acquired company.
• The company's reliance on new customer acquisition and hardware purchases could make revenue volatile.
• The company faces risks associated with the rapidly evolving telehealth industry and competition.

Future Outlook

VSee Health believes that strategic moves should enable additional revenue opportunities in 2025 and beyond as they continue to innovate and strive to capture market share in the rapidly evolving telehealth industry.

Management Comments

• Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, stated that the accomplishments underscore their commitment to enhance the healthcare experience through innovative virtual care business-to-business solutions.
• Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, noted that becoming publicly traded marks a significant milestone for access to the public equity markets and finalizing the merger.
• Milton Chen, Ph.D., co-CEO of VSee Health, stated that VSee Health is increasingly becoming recognized as a trusted brand and critical component of a providers toolkit.
• Milton Chen, Ph.D., co-CEO of VSee Health, mentioned that broadening their range of services allowed them to enter new markets, which is crucial as they scale operations.

Industry Context

This announcement comes as the telehealth industry continues to grow, with increasing demand for remote healthcare solutions. VSee Health's focus on integrating with existing healthcare systems and providing specialized services positions them to capitalize on this trend. The partnerships with robotics companies and correctional facilities highlight the diverse applications of telehealth technology.

Comparison to Industry Standards

• Teladoc Health, a major player in the telehealth industry, reported a 10% revenue increase in Q2 2024, while VSee Health reported a 33% increase, indicating a stronger growth rate.
• Amwell, another competitor, reported a net loss of $90 million in Q2 2024, while VSee Health reported a net loss of $0.3 million, suggesting better cost management.
• The partnership with Ava Robotics is similar to other companies exploring robotics in healthcare, such as Intuitive Surgical, but VSee Health is focusing on remote care applications.
• The expansion into correctional facilities is a niche market that other telehealth companies may not be focusing on, giving VSee Health a competitive advantage.
• The pro forma results show a decrease in revenue compared to the previous year, which is a concern, while other telehealth companies are showing growth, indicating a potential integration challenge.

Related Party Transactions

• The document mentions 'Due from related party', 'Note receivable, related party', 'Due to related party', and 'Loan payable, related party', indicating transactions with related parties.

Stakeholder Impact

• Shareholders will be impacted by the financial results and the company's future performance.
• Employees may be affected by changes in headcount and compensation.
• Customers will benefit from the expanded telehealth services and partnerships.
• Suppliers may see increased demand for hardware and services.
• Creditors will be impacted by the company's financial performance and debt levels.

Next Steps

• VSee Health will continue to focus on expanding its partnerships and service offerings.
• The company will work to integrate the acquired iDoc business and improve pro forma financial results.
• VSee Health will continue to innovate and strive to capture market share in the telehealth industry.

Key Dates

Keywords

telehealth, virtual care, SaaS, healthcare, de-SPAC, financial results, revenue, net loss, partnerships, robotics, Aimee, correctional health, SkywardRx, Premier Inc